愛爾眼科醫院集團
AIER Eye Hospital Group is China’s leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) ，Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are more than 500 in Mainland China, 7 in Hong Kong, 1 in the United States, more than 80 in Europe, and 12 in Southeast Asia.
愛爾眼科致力于引(yin)進和吸收國際同步的(de)眼科技術與醫療(liao)管理理念(nian)，以專業化、規模化、科學(xue)化為發展戰略，推動中國眼科醫療(liao)事(shi)業的(de)發展。
AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care.
通(tong)過不(bu)斷(duan)的(de)(de)(de)探(tan)(tan)索(suo)(suo)與實踐，并(bing)充分吸納國際先(xian)進的(de)(de)(de)醫(yi)(yi)療管(guan)理經(jing)驗的(de)(de)(de)基礎上，成(cheng)(cheng)功(gong)探(tan)(tan)索(suo)(suo)出一套適應中國國情和(he)市(shi)場環境的(de)(de)(de)眼(yan)科醫(yi)(yi)院(yuan)連(lian)鎖(suo)經(jing)營管(guan)理模式——“分級(ji)連(lian)鎖(suo)”。利用人才(cai)、技術和(he)管(guan)理等方面的(de)(de)(de)優(you)勢，通(tong)過全國各連(lian)鎖(suo)醫(yi)(yi)院(yuan)優(you)良的(de)(de)(de)診療質量、優(you)質的(de)(de)(de)醫(yi)(yi)療服(fu)務和(he)良好的(de)(de)(de)醫(yi)(yi)患溝通(tong)，使愛爾(er)眼(yan)科成(cheng)(cheng)為(wei)全國各地眼(yan)科患者信賴的(de)(de)(de)眼(yan)科醫(yi)(yi)院(yuan)。
Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication.
2013年，愛爾(er)眼(yan)(yan)(yan)科醫(yi)院(yuan)(yuan)集團(tuan)與(yu)中南(nan)(nan)大學(xue)(xue)聯合成立專業(ye)的眼(yan)(yan)(yan)科醫(yi)學(xue)(xue)院(yuan)(yuan)——中南(nan)(nan)大學(xue)(xue)愛爾(er)眼(yan)(yan)(yan)科學(xue)(xue)院(yuan)(yuan)，主要培養眼(yan)(yan)(yan)科碩、博士(shi)精英醫(yi)療(liao)人才，開啟了社會(hui)資本參與(yu)醫(yi)學(xue)(xue)教育(yu)的有益創新和探索(suo);
2014年，與湖北(bei)科技大學(xue)聯合成(cheng)立愛爾(er)眼(yan)視光學(xue)院(yuan)，旨在培養眼(yan)視光學(xue)的專業(ye)技術人(ren)才(cai)。
2019年，新增武漢大學愛爾眼科臨(lin)床學院及(ji)研究院。
與(yu)此同時，自2015年愛(ai)爾眼(yan)科(ke)(ke)先(xian)后成立愛(ai)爾眼(yan)科(ke)(ke)研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)、愛(ai)爾眼(yan)視(shi)光研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)、角(jiao)膜病(bing)研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)、白內障研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)、青光眼(yan)研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)、視(shi)網膜研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)和(he)屈光研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)等(deng)7大研(yan)(yan)(yan)(yan)(yan)究(jiu)所(suo)，旨在(zai)推(tui)動(dong)眼(yan)科(ke)(ke)學、視(shi)覺(jue)科(ke)(ke)學以及各亞專(zhuan)科(ke)(ke)前沿和(he)臨(lin)床應(ying)用技術的(de)研(yan)(yan)(yan)(yan)(yan)究(jiu)和(he)創新。
愛爾(er)眼(yan)科(ke)通(tong)過成立學院和(he)研究所等機構，正式打通(tong)了(le)眼(yan)科(ke)的醫、學、研三大領域，使(shi)愛爾(er)眼(yan)科(ke)的科(ke)研及(ji)臨床(chuang)水平(ping)得到(dao)顯著提升，并以此(ci)推動中國眼(yan)科(ke)醫療事業(ye)的發展和(he)進(jin)步。
In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees，which opened a new era for social capital to be involved in medical education.
In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry.
In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found.
Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmology Institute, AIER Optometry Institute, AIER Refraction Institute, AIER Corneal Institute, AIER Glaucoma Institute, AIER Retinology Institute, and AIER Cataract Institute.
At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.
在快速跨越(yue)式發(fa)展的(de)過程中，愛(ai)爾眼(yan)科凝聚和(he)培養了一批(pi)經(jing)驗(yan)豐富、開拓創新的(de)管理團(tuan)(tuan)隊(dui)和(he)醫(yi)術精(jing)良、治學(xue)嚴謹(jin)的(de)眼(yan)科專家和(he)醫(yi)生團(tuan)(tuan)隊(dui)。截(jie)止2020年4月，愛(ai)爾眼(yan)科集團(tuan)(tuan)及旗下全(quan)球員工總數(shu) 36,000余人，其中眼(yan)科及視(shi)光醫(yi)生總數(shu)(含海外(wai))7,400余人，包括一大(da)批(pi)碩士(shi)生導(dao)師、博(bo)士(shi)生導(dao)師、博(bo)士(shi)、博(bo)士(shi)后(hou)、留學(xue)歐(ou)美(mei)的(de)學(xue)者以(yi)及臨床經(jing)驗(yan)豐富的(de)核心專家，是(shi)中國眼(yan)科領域備受(shou)矚目的(de)有生力(li)量。
In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of April, 2020，AIER has more than 36,000 employees globally, including 7,400 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, PH.D supervisor, Ph.D, Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China.
愛爾眼(yan)科(ke)的(de)發(fa)展(zhan)壯大，始(shi)終以“使(shi)所有人，無(wu)論貧(pin)窮富(fu)裕，都享有眼(yan)健(jian)康(kang)的(de)權利”為使(shi)命，追求(qiu)社會責任(ren)和自身發(fa)展(zhan)的(de)和諧統一，通過開創性的(de)“交叉補(bu)貼”模式，一方面為患(huan)者提(ti)供更(geng)高品質(zhi)的(de)眼(yan)科(ke)醫療服務，同時全(quan)面開展(zhan)防盲治盲工作(zuo)、投身社會公益和幫(bang)助弱勢群體，并聯合(he)社會各(ge)界，推動整個中國防盲事業乃至國民眼(yan)健(jian)康(kang)事業的(de)全(quan)面發(fa)展(zhan)。
Since its founding, AIER always committed to the mission,“Enabling everyone, whether rich or poor, has the right to eye health.”With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health.
隨(sui)著中(zhong)國醫(yi)療衛(wei)生體制改(gai)革的(de)進一步推進，愛爾眼(yan)科(ke)順應國家醫(yi)療衛(wei)生政(zheng)策(ce)和發展趨勢，適時在醫(yi)療行業推出“合伙人(ren)計劃”，致(zhi)力于(yu)改(gai)變眼(yan)科(ke)醫(yi)生執業的(de)生態環(huan)境(jing)，最大限度地激發核(he)心(xin)骨干的(de)創(chuang)造(zao)力和能動性，為(wei)推動公司規模與效益的(de)同步提高注入持(chi)續發展的(de)關鍵(jian)動力。愛爾眼(yan)科(ke)專(zhuan)(zhuan)注于(yu)眼(yan)科(ke)醫(yi)療服務(wu)事(shi)業，將在全國的(de)城(cheng)鄉縣(xian)域(yu)興(xing)建各級專(zhuan)(zhuan)業連鎖(suo)眼(yan)科(ke)醫(yi)院，為(wei)更多的(de)人(ren)提供高質量、多層次的(de)眼(yan)科(ke)醫(yi)療服務(wu)。
With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER’s scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.